Contact information for the PREVENT-Alzheimer study

Research team of the PREVENT-Alzherimer Program.  

The goal of the PREVENT-AD program is to study memory and brain changes in healthy people over the age of 60.

McGill and the Douglas have joined hands to create the StoP-AD Centre dedicated to the prevention of AD.

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

Prevent-Alzheimer is a Program comprising of a study conducted by the StoP-AD Centre.

Most anxiety disorders are treated with cognitive-behavioral therapy (CBT), medication, or a combination of the two.

The Medical Records Department is responsible for protecting personal information and preserving patient charts.

Martin Lepage team is currently working on these clinically-based research projects.

Martin Lepage's team is working on the following neurocognitive and neuroimaging research projects.